Nemonic Dot solves a simple but important access problem in a way that could scale fast through pharmacies, public services and everyday settings. Its agreement with a 25,000-pharmacy network shows real potential for wide, practical impact. 

Nemonic Dot is solving a practical but overlooked accessibility problem. Braille labelling is still too hard to create for many of the people who need it most, including blind and visually impaired people, carers, pharmacists and public service staff. Existing portable printers often produce low-quality dots, can be hard to use, and usually require Braille literacy. Nemonic Dot changes that with a portable printer and app that turns speech or typed text into Braille instantly, with no specialist knowledge needed. Its patent-pending mechanism produces 0.6 mm dots that meet international standards and can emboss durable metal labels. The impact potential is significant. In January 2026, the company signed an agreement with the Korean Pharmaceutical Association, which represents more than 25,000 pharmacies. Independent evaluators rated it better than existing portable Braille devices across portability, usability, durability and dot quality. The result is a more scalable and safer way to create Braille labels for medication, public services and everyday life, reducing exclusion and making independent access much more practical.